Status:
UNKNOWN
Use of Warfarin After the First Trimester in Pregnant Women With APS
Lead Sponsor:
Mohamed Sayed Abdelhafez
Conditions:
Recurrent Miscarriage
Antiphospholipid Syndrome
Eligibility:
FEMALE
20-38 years
Phase:
PHASE4
Brief Summary
Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with antiphospholipid syndrome...
Detailed Description
Women will be randomly divided into two groups; one will be subjected to anticoagulant therapy by Enoxaparin throughout pregnancy and the other will be subjected to anticoagulant therapy by Enoxaparin...
Eligibility Criteria
Inclusion
- Pregnant women with APS diagnosed according to the revised classification criteria for APS in 2006 in Sydney, Australia
- Early pregnancy body weight is 50-90 Kg
Exclusion
- Women with systemic lupus erythematosus (SLE)
- Women with active thromboembolic disorders
- Women with history of previous thromboembolic disorders
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02303171
Start Date
November 1 2014
End Date
June 1 2025
Last Update
October 31 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Obstetrics and Gynecology Department in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35111
2
Private practice settings
Al Mansurah, Dakahlia Governorate, Egypt